Report Highlights
The global market for vaccine delivery devices should grow from $3.7 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 3.8% for the period of 2021-2026.
Report Includes
- 55 tables
- An overview of the global markets for vaccine delivery systems
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast and technological advancements and strategic innovations within the industry
- Highlights of the market potential for vaccine delivery systems by type of device, route of administration, end user, and region
- Discussion on vaccines limitations like inefficient activation of a cell-mediated immune response and the deficiency of protective mucosal immunity, and information on gene-based vaccines like DNA & m-RNA vaccines
- Coverage of recent developments which have been focused on intradermal vaccine formulations for vaccine delivery devices to activate both a systemic and mucosal immune response
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Profile descriptions of the leading industry players including ApiJect Systems Corp., Corium Inc., Enesi Pharma, Hindustan Syringes & Medical Devices Ltd., PharmaJet, SCHOTT, and Vaxxas6
Report Scope
This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery devices. The report also includes recent technological developments and assessments of product performance in the market.
Based on the device type, the vaccine delivery device market is segmented into syringes, jet injectors and other novel technologies (e.g., microneedle patches, electroporation-based needle-free injection system, nasal spray, etc.).
Based on the route of administration, the vaccine delivery device market is segmented into intramuscular injection, subcutaneous injection and other routes of administration (intradermal, oral route, etc.).
Based on end-users, the vaccine delivery device market is segmented into hospitals, clinics and other end-users (vaccination centers, tertiary care centers, etc.).
The report includes a list of pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing the market growth, as well as market drivers, restraints and opportunities.
This report also discusses competition in the global vaccine delivery device market and the key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report provides insights on the market share and upcoming regional demand for vaccine delivery devices.
Some of the major market players discussed in the report are BD, ApiJect Systems Corp., Hindustan Syringes & Medical Devices Ltd., Terumo Corp. and Smiths Medical. For market estimates, data has been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Water and Wastewater Pipes Market (ENV071A)
- Plant-based Meat: Global Markets (FOD098B)
- Prefilled Syringes: Global Markets (HLC223B)
- Global Sustainable Marine Fuel Market (EGY198A)
- Gene Synthesis: Technologies and Global Markets (BIO251A)
Related Reports
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Nasal Vaccines: Global Markets and Pipeline Analysis
The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.
Influenza Vaccines: Global Markets
The global influenza vaccines market is estimated to increase from $6.9 billion in 2021 to $10.1 billion by 2026, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2021-2026.
2021 Medical Devices Research Review
The global contract manufacturing of medical devices market should reach $108.6 billion by 2025 from $68.0 billion in 2020 at a CAGR of 9.8% for the forecast period of 2020 to 2025.
Recent Reports
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Global Medical Dynamometer Market
The global market for medical dynamometers is estimated to increase from $547.5 million in 2023 to reach $780.1 million by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028.
Global Insulin Pen Market
This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.
Top Trending Reports
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
3D Cell Cultures: Technologies and Global Markets
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More